SCHEMBL26705642

SCHEMBL26705642

O=C(OC1C2CCC(CC2)C1OC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 3/20 0.53
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
HTR3E A5X5Y0 1/20 0.50
HTR3B O95264 1/20 0.50
HTR3A P46098 1/20 0.50
HTR3D Q70Z44 1/20 0.50
HTR3C Q8WXA8 1/20 0.50
F2 P00734 1/20 0.50
LMNA P02545 1/20 0.50
APOBEC3A P31941 1/20 0.49
APOBEC3G Q9HC16 1/20 0.49
OPRM1 P35372 1/20 0.48
OPRD1 P41143 1/20 0.48
SCN1A P35498 1/20 0.47
SCN2A Q99250 1/20 0.47
SCN3A Q9NY46 1/20 0.47
GAA P10253 1/20 0.47
TSHR P16473 1/20 0.47
CHRM2 P08172 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27138259 1.00 CHRNA7 (0.53) CHRNA7MEN1KMT2AHTR3EHTR3B
SCHEMBL27134136 0.94 CHRNA7 (0.49) CHRNA7MEN1KMT2AHTR3EHTR3B
SCHEMBL27134132 0.94 CHRM2 (0.50) CHRNA7MEN1KMT2AHTR3EHTR3B
SCHEMBL27134146 0.93 CHRNA7 (0.47) CHRNA7MEN1KMT2AHTR3EHTR3B
SCHEMBL27134133 0.92 CHRM2 (0.51) CHRNA7MEN1KMT2AHTR3EHTR3B
SCHEMBL27134141 0.92 CHRNA7 (0.50) CHRNA7MEN1KMT2AHTR3EHTR3B
SCHEMBL27134165 0.91 SCN1A (0.59) CHRNA7MEN1KMT2AHTR3EHTR3B
SCHEMBL27138169 0.91 CHRNA7 (0.49) CHRNA7MEN1KMT2AHTR3EHTR3B
SCHEMBL27134150 0.91 CHRNA7 (0.49) CHRNA7MEN1KMT2AHTR3EHTR3B
SCHEMBL27134137 0.91 CHRM2 (0.50) CHRNA7MEN1KMT2AHTR3EHTR3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067764-A1 SOLID TITANIUM CATALYST COMPONENT, OLEFIN POLYMERIZATION CATALYST, OLEFIN POLYMERIZATION METHOD, AND PROPYLENE POLYMER MITSUI CHEMICALS, INC. (JP) 2024-02-29 US disclosed
US-20240067764-A1 SOLID TITANIUM CATALYST COMPONENT, OLEFIN POLYMERIZATION CATALYST, OLEFIN POLYMERIZATION METHOD, AND PROPYLENE POLYMER MITSUI CHEMICALS, INC. (JP) 2024-02-29 US disclosed
US-20240067597-A1 ESTER COMPOUND MITSUI CHEMICALS, INC. (JP) 2024-02-29 US disclosed
US-20240067597-A1 ESTER COMPOUND MITSUI CHEMICALS, INC. (JP) 2024-02-29 US disclosed
EP-4265593-A1 ESTER COMPOUND Mitsui Chemicals, Inc. (JP) 2023-10-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240067597-A1 ESTER COMPOUND PPT1, GPER1, TCP1 CHRNA7 2463/4885MEN1 2318/4885KMT2A 2843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.